PhenixFIN (PFXNZ) Cash & Equivalents (2021 - 2026)

PhenixFIN (PFXNZ) has reported Cash & Equivalents for 6 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 70.04% year-over-year to $2.2 million in Q2 2026; TTM through Jun 2026 was $2.2 million, a 70.04% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 89.21% from the prior year.
• Cash & Equivalents was $2.2 million for Q2 2026 at PhenixFIN, down from $3.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $67.6 million in Q3 2024 and troughed at $2.2 million in Q2 2026.
• A 5-year average of $15.4 million and a median of $9.8 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 1028.41% in 2024 and tumbled 89.21% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $17.7 million in 2022, then tumbled by 31.04% to $12.2 million in 2023, then sank by 40.96% to $7.2 million in 2024, then slumped by 52.6% to $3.4 million in 2025, then slumped by 36.07% to $2.2 million in 2026.
• The last three Cash & Equivalents figures came in at $2.2 million (Q2 2026), $3.1 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.